Rapid Micro Biosystems Awarded Contract by Biomedical Advanced Research and Development Authority (BARDA) to Develop Rapid Sterility Testing Platform for Vaccines

BEDFORD, Mass.--(BUSINESS WIRE)--Rapid Micro Biosystems, a leading provider of automated, non-destructive, rapid microbial detection, today announced that it has signed a contract with the Biomedical Advanced Research and Development Authority (BARDA) for the development of rapid sterility testing for vaccines as part of the Innovative Platform Technologies program of BARDA’s Strategic Science and Technology Division.

MORE ON THIS TOPIC